A study by Arrambide and colleagues in 2015 found that CSF CHI3L1 levels were significantly higher in MS patients with cognitive impairment compared to those without, and that higher CHI3L1 levels were associated with more severe cognitive impairment, particularly in the domains of verbal memory and attention [39]. The gene discussed is CHI3L1; the disease is Cognitive impairment.